<span item_type="fundamental" item_id="70dbb78277622fb84a632fea74a26deb" counter_id="ST/US/VSEE" env="prod"></span><span item_type="announcement" item_id="571931489072845953" env="prod"></span><p>Revenue: As of FY2025 Q2, the actual value is USD 3.39 M.</p><p>EPS: As of FY2025 Q2, the actual value is USD -0.16.</p><p>EBIT: As of FY2025 Q2, the actual value is USD -2.014 M.</p><p></p><h3>Segment Revenue</h3><ul><li><strong>Technology Segment</strong>: Revenue for the six months ended June 30, 2025, was $4,458,800, compared to $3,269,992 for the same period in 2024, representing an increase of $1,188,808 or 36%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1864531/000118518525001450/vsee10q063025.htm"></span></li><li><strong>Telehealth Segment</strong>: Revenue for the six months ended June 30, 2025, was $2,252,805, compared to $62,569 for the same period in 2024, representing an increase of $2,190,236 or 3,501%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1864531/000118518525001450/vsee10q063025.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Gross Margin</strong>: For the six months ended June 30, 2025, the Technology segment reported a gross margin of $2,023,181, while the Telehealth segment reported a gross margin of $1,425,282.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1864531/000118518525001450/vsee10q063025.htm"></span></li><li><strong>Operating Income (Loss)</strong>: The Technology segment reported an operating loss of - $83,969 for the six months ended June 30, 2025, while the Telehealth segment reported an operating loss of - $1,300,001.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1864531/000118518525001450/vsee10q063025.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Used in Operating Activities</strong>: For the six months ended June 30, 2025, net cash used in operating activities was - $765,094, compared to - $2,594,214 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1864531/000118518525001450/vsee10q063025.htm"></span></li><li><strong>Net Cash Used in Investing Activities</strong>: For the six months ended June 30, 2025, net cash used in investing activities was - $15,466, compared to - $16,390 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1864531/000118518525001450/vsee10q063025.htm"></span></li><li><strong>Net Cash Provided by Financing Activities</strong>: For the six months ended June 30, 2025, net cash provided by financing activities was $746,040, compared to $3,597,841 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1864531/000118518525001450/vsee10q063025.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Amortization Expense</strong>: For the six months ended June 30, 2025, the Company recorded amortization expense of $1,149,998 within general and administrative expenses.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1864531/000118518525001450/vsee10q063025.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The Company plans to leverage its industry relationships with government, hospital systems, and insurance providers to increase its customer base and expand within the telehealth market.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1864531/000118518525001450/vsee10q063025.htm"></span></li><li><strong>Non-Core Business</strong>: The Company is exploring additional financing options to support its working capital needs and fund growth initiatives.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1864531/000118518525001450/vsee10q063025.htm"></span></li></ul><h3>Priority</h3><ul><li>The Company emphasizes strategies with concrete projections, such as expanding its telehealth offerings and leveraging its scalable technology platform to meet the unique needs of the healthcare industry.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1864531/000118518525001450/vsee10q063025.htm"></span></li></ul>

VSee Health | 10-Q: FY2025 Q2 Revenue: USD 3.39 M